Marudachalam, Jeevitha http://orcid.org/0000-0001-6124-8403
Ravichandhiran, Oviyha http://orcid.org/0000-0003-0625-9980
Ramalingam, Kameswaran http://orcid.org/0000-0003-1219-807X
Ramanathan, Sambathkumar http://orcid.org/0000-0003-1454-9582
Mahaboob, Sirajudeen http://orcid.org/0000-0001-5946-0587
Abdul Razack, Habeeb Ibrahim http://orcid.org/0000-0002-3458-2219
Article History
Accepted: 23 January 2022
First Online: 10 February 2022
Declarations
:
: The authors did not receive grants from any commercial, governmental, or non-profit organizations related to this work.
: The authors declare that they have no competing interests.
: The study protocol, questionnaire, informed consent, and study participation and publication details, COVID-19 awareness brochure, and appreciation certificate were reviewed and approved by the JKK Nataraja Institutional Ethics Committee (IEC) with an ethical clearance certificate (number: JKKNCP/ETHICS_PRACTICE/020PDS11) on 17 Apr 2020.
: IEC-approved consent statements to participate and publish were introduced at the beginning of the questionnaire. Participants who voluntarily agreed to participate/publish proceeded further to answer the survey questions.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: The opinions expressed in this article are the authors’ personal views and do not represent that of their affiliated organizations or associations.
: KR and SR conceived the research idea. JM and OR designed the questionnaire, and KR helped to validate it. JM and OR conducted the pre-test analysis. SM performed the statistical analysis and interpreted the findings with inputs from KR and SR. JM and OR drafted the manuscript. HI reviewed, edited, and revised the manuscript and added substantial intellectual content. All authors read and approved the final version and agreed to submit it to <i>Drugs & Therapy Perspectives</i> for consideration.
Free to read: This content has been made available to all.